Microbial regulation of the keratinocyte AHR
角质形成细胞 AHR 的微生物调节
基本信息
- 批准号:10599330
- 负责人:
- 金额:$ 55.72万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-04-01 至 2027-03-31
- 项目状态:未结题
- 来源:
- 关键词:AdhesionsAgonistAntibioticsAryl Hydrocarbon ReceptorAtopic DermatitisBacterial InfectionsBiochemicalBiologyCalcipotrieneCellsChronicCollaborationsCutaneousDataDefectDiseaseEnsureEpitheliumFlowersFunctional disorderGenetic TranscriptionGerm-FreeGoalsHomeostasisHumanIn VitroInfectionInfection preventionInfectious Skin DiseasesInflammationInflammatoryInjuryInnate Immune ResponseLigandsMediatingMediatorMicrobeModelingMolecularMusNamesOvalbuminPathologyPathway interactionsPattern recognition receptorPermeabilityPharmacodynamicsPoisonPredispositionPreventionReceptor ActivationReceptor SignalingRegulationRelapseResearchRoleSkinStaphylococcus aureusStaphylococcus aureus infectionSymbiosisTestingTherapeuticTight JunctionsTissuesTryptophanXenobioticsantimicrobialantimicrobial peptidearyl hydrocarbon receptor ligandcommensal bacteriadysbiosisefficacy evaluationhost microbiotaimprovedin vivoinjury recoveryinsightkeratinocytemicrobialmicrobial colonizationmicrobial communitymicrobiotamouse modelmultiple omicsnovelpathogenpreventreceptorrepairedsafety assessmentskin barrierskin disorderskin lesion
项目摘要
PROJECT SUMMARY
The complexity of microbial communities inhabiting the healthy human skin have been illuminated in recent
years, as well as signatures associated with inflammatory skin diseases such as atopic dermatitis. However,
the molecular and biochemical mechanisms that mediate microbial symbiosis with the skin are not well
understood. We recently found that homeostatic skin barrier function, epidermal differentiation, and recovery
from injury are dependent on the microbiota in mice. These effects were mediated by the keratinocyte aryl
hydrocarbon receptor (AHR). The AHR is a ligand-dependent xenobiotic receptor of foreign/toxic substances
that is also known to regulate epidermal differentiation, tight junction/adhesion, and antimicrobial innate
immune responses. The objective of this project is to identify and characterize microbial ligands of the AHR,
and to test their utility in treating skin barrier dysfunction and infection. Epidermal barrier dysfunction is a key
feature of atopic dermatitis, a common skin disorder characterized by chronic and relapsing, itchy, inflamed,
skin lesions and dysbiotic microbiota. To test the hypothesis that commensal bacteria mediate AHR signaling
to promote skin barrier integrity and defense, we propose three aims. 1) Define microbial mechanisms of
keratinocyte AHR regulation that promote barrier repair; 2) Establish pharmacodynamic actions of microbial
AHR ligands to promote skin barrier function and antimicrobial defense; and 3) Evaluate microbial AHR ligands
in treatment of epidermal barrier dysfunction and S. aureus infection in murine models. Findings from these
studies will provide novel, accessible targets to promote skin barrier function and repair, while advancing
fundamental understanding of cutaneous host-microbiota interactions.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Elizabeth Anne Grice其他文献
Elizabeth Anne Grice的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Elizabeth Anne Grice', 18)}}的其他基金
Skin microbiome regulation of the sebum-immune axis
皮肤微生物组对皮脂免疫轴的调节
- 批准号:
10732282 - 财政年份:2023
- 资助金额:
$ 55.72万 - 项目类别:
Microbial regulation of the keratinocyte AHR
角质形成细胞 AHR 的微生物调节
- 批准号:
10467133 - 财政年份:2022
- 资助金额:
$ 55.72万 - 项目类别:
Skin microbiome contributions to the pathogenesis of cutaneous leishmaniasis
皮肤微生物组对皮肤利什曼病发病机制的贡献
- 批准号:
9884728 - 财政年份:2019
- 资助金额:
$ 55.72万 - 项目类别:
Skin microbiome contributions to the pathogenesis of cutaneous leishmaniasis
皮肤微生物组对皮肤利什曼病发病机制的贡献
- 批准号:
10349537 - 财政年份:2019
- 资助金额:
$ 55.72万 - 项目类别:
Skin microbiome contributions to the pathogenesis of cutaneous leishmaniasis
皮肤微生物组对皮肤利什曼病发病机制的贡献
- 批准号:
10582641 - 财政年份:2019
- 资助金额:
$ 55.72万 - 项目类别:
Penn Skin Biology and Diseases Resource-based Center
宾夕法尼亚大学皮肤生物学和疾病资源中心
- 批准号:
10663977 - 财政年份:2016
- 资助金额:
$ 55.72万 - 项目类别:
Penn Skin Biology and Diseases Resource-based Center
宾夕法尼亚大学皮肤生物学和疾病资源中心
- 批准号:
10477227 - 财政年份:2016
- 资助金额:
$ 55.72万 - 项目类别:
Decoding the microbial burden in diabetic foot ulcers
解读糖尿病足溃疡的微生物负荷
- 批准号:
10159971 - 财政年份:2015
- 资助金额:
$ 55.72万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 55.72万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 55.72万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 55.72万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 55.72万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 55.72万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 55.72万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 55.72万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 55.72万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 55.72万 - 项目类别:
Fentanyl Addiction: Individual Differences, Neural Circuitry, and Treatment with a GLP-1 Receptor Agonist
芬太尼成瘾:个体差异、神经回路和 GLP-1 受体激动剂治疗
- 批准号:
10534864 - 财政年份:2023
- 资助金额:
$ 55.72万 - 项目类别:














{{item.name}}会员




